ContraFect Corporation
CFRXQ · OTC
9/30/2023 | 6/30/2023 | 3/31/2023 | 12/31/2022 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $39 | $41 | $40 | $39 |
| Gross Profit | -$39 | -$41 | -$40 | -$39 |
| % Margin | – | – | – | – |
| R&D Expenses | $3,869 | $4,870 | $5,295 | $4,438 |
| G&A Expenses | $0 | $0 | $0 | $2,265 |
| SG&A Expenses | $2,769 | $3,064 | $3,523 | $2,226 |
| Sales & Mktg Exp. | $0 | $0 | $0 | -$39 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $6,638 | $7,934 | $8,818 | $6,664 |
| Operating Income | -$6,677 | -$7,975 | -$8,858 | -$6,703 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | $1,318 | $407 | $7,487 | -$3,137 |
| Pre-Tax Income | -$5,359 | -$7,568 | -$1,371 | -$9,839 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$5,359 | -$7,568 | -$1,371 | -$9,839 |
| % Margin | – | – | – | – |
| EPS | -0.5 | -1.94 | -0.69 | -16.14 |
| % Growth | 74.2% | -181.2% | 95.7% | – |
| EPS Diluted | -0.5 | -1.94 | -0.69 | -16.14 |
| Weighted Avg Shares Out | 10,705 | 3,902 | 1,975 | 610 |
| Weighted Avg Shares Out Dil | 10,705 | 3,902 | 1,975 | 610 |
| Supplemental Information | – | – | – | – |
| Interest Income | $109 | $114 | $87 | $17 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $39 | $41 | $40 | $39 |
| EBITDA | -$6,638 | -$7,934 | -$8,818 | -$6,665 |
| % Margin | – | – | – | – |